To the Editor:Neuropsychiatric systemic lupus erythematosus(NPSLE)is a group of serious complications of systemic lupus erythematosus(SLE)with poor prognosis and high mortality.^([1])Therefore,identifying risk factors...To the Editor:Neuropsychiatric systemic lupus erythematosus(NPSLE)is a group of serious complications of systemic lupus erythematosus(SLE)with poor prognosis and high mortality.^([1])Therefore,identifying risk factors for NPSLE is particularly crucial for the improvement of the outcomes of patients.Magnetic resonance imaging(MRI)is currently the imaging test of choice for diagnosing patients with NPSLE.However,almost half of the patients with NPSLE show no abnormalities on conventional MRI.^([2])Therefore,the correlation between neuropsychiatric symptoms,which refer to multiple neuropsychiatric manifestations directly related to SLE,and MRI findings should be urgently studied.In this study,we investigated the clinical features,outcomes,and prognostic factors of NPSLE and analyzed the correlation of neuropsychiatric symptoms with MRI features.展开更多
Immunoglobulin G4-related disease(IgG4-RD)is a newly recognized chronic fibro-inflammatory autoimmune disease,and its recognition has been constantly increasing worldwide over the last few years.A correct and timely r...Immunoglobulin G4-related disease(IgG4-RD)is a newly recognized chronic fibro-inflammatory autoimmune disease,and its recognition has been constantly increasing worldwide over the last few years.A correct and timely recognition,as well as appropriate intervention,is crucial for the treatment of IgG4-RD.For certain subtypes of IgG4-RD,organ-specific criteria are formulated to make the diagnosis more accurate.New biomarkers have emerged in the recent years to aid the disease diagnosis,its prognosis prediction,as well as therapy response monitoring.Although recurrence is very common in IgG4-RD,glucocorticoid is still the first-line treatment for the majority of patients.The factors that affect the likelihood of disease relapse are multifaceted.The selection strategy of various steroid-sparing agents is still being explored.Besides,when patients have special sites involvement leading to severe clinical conditions,surgical operation or interventional therapy should also be considered.An update on classification,diagnosis,and management of IgG4-RD is provided in the current study to fully elucidate the recommended clinical practice of this mysterious disease.展开更多
基金supported by grants from the National Natural Science Foundation of China(No.82271847)Hubei Provincial Natural Science Foundation Joint Fund for Innovation and Development Project(No.2023AFD046)Tongji Hospital Scientific Research Fund(No.2022B09)
文摘To the Editor:Neuropsychiatric systemic lupus erythematosus(NPSLE)is a group of serious complications of systemic lupus erythematosus(SLE)with poor prognosis and high mortality.^([1])Therefore,identifying risk factors for NPSLE is particularly crucial for the improvement of the outcomes of patients.Magnetic resonance imaging(MRI)is currently the imaging test of choice for diagnosing patients with NPSLE.However,almost half of the patients with NPSLE show no abnormalities on conventional MRI.^([2])Therefore,the correlation between neuropsychiatric symptoms,which refer to multiple neuropsychiatric manifestations directly related to SLE,and MRI findings should be urgently studied.In this study,we investigated the clinical features,outcomes,and prognostic factors of NPSLE and analyzed the correlation of neuropsychiatric symptoms with MRI features.
基金This work was supported by grants from the National Natural Science Foundation of China(Nos.81771754 and 81901651)the Tongji Hospital Clinical Research Flagship Program(No.2019CR206)。
文摘Immunoglobulin G4-related disease(IgG4-RD)is a newly recognized chronic fibro-inflammatory autoimmune disease,and its recognition has been constantly increasing worldwide over the last few years.A correct and timely recognition,as well as appropriate intervention,is crucial for the treatment of IgG4-RD.For certain subtypes of IgG4-RD,organ-specific criteria are formulated to make the diagnosis more accurate.New biomarkers have emerged in the recent years to aid the disease diagnosis,its prognosis prediction,as well as therapy response monitoring.Although recurrence is very common in IgG4-RD,glucocorticoid is still the first-line treatment for the majority of patients.The factors that affect the likelihood of disease relapse are multifaceted.The selection strategy of various steroid-sparing agents is still being explored.Besides,when patients have special sites involvement leading to severe clinical conditions,surgical operation or interventional therapy should also be considered.An update on classification,diagnosis,and management of IgG4-RD is provided in the current study to fully elucidate the recommended clinical practice of this mysterious disease.